144 related articles for article (PubMed ID: 25124939)
1. Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: a randomized, multicentre, placebo-controlled double-blind phase II trial.
Pflugfelder A; Andonov E; Weide B; Dirschka T; Schempp C; Stockfleth E; Stratigos A; Krüger-Krasagakis S; Bauer J; Garbe C; Eigentler TK
Br J Dermatol; 2015 Apr; 172(4):926-32. PubMed ID: 25124939
[TBL] [Abstract][Full Text] [Related]
2. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study.
Huyke C; Reuter J; Rödig M; Kersten A; Laszczyk M; Scheffler A; Nashan D; Schempp C
J Dtsch Dermatol Ges; 2009 Feb; 7(2):128-33. PubMed ID: 18808378
[TBL] [Abstract][Full Text] [Related]
3. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Stockfleth E; Kerl H; Zwingers T; Willers C
Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
[TBL] [Abstract][Full Text] [Related]
4. OLEOGEL-S10 TO ACCELERATE HEALING OF DONOR SITES: MONOCENTRIC RESULTS OF PHASE III CLINICAL TRIAL.
Lipový B; Fiamoli M; Mager R; Jelínková Z; Jarkovský J; Chaloupková Z; Holoubek J; Suchánek I; Brychta P
Acta Chir Plast; 2018; 59(3-4):129-134. PubMed ID: 29651853
[TBL] [Abstract][Full Text] [Related]
5. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Oleogel-S10: A triterpene preparation for the treatment of epidermolysis bullosa.
Schwieger-Briel A; Ott H; Kiritsi D; Laszczyk-Lauer M; Bodemer C
Dermatol Ther; 2019 Jul; 32(4):e12983. PubMed ID: 31168940
[TBL] [Abstract][Full Text] [Related]
7. Oleogel-S10 Phase 3 study "EASE" for epidermolysis bullosa: study design and rationale.
Kern JS; Schwieger-Briel A; Löwe S; Sumeray M; Davis C; Martinez AE
Trials; 2019 Jun; 20(1):350. PubMed ID: 31186047
[TBL] [Abstract][Full Text] [Related]
8. Betulin wound gel accelerated healing of superficial partial thickness burns: Results of a randomized, intra-individually controlled, phase III trial with 12-months follow-up.
Frew Q; Rennekampff HO; Dziewulski P; Moiemen N; ; Zahn T; Hartmann B
Burns; 2019 Jun; 45(4):876-890. PubMed ID: 30559054
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1278-82. PubMed ID: 24196337
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
[TBL] [Abstract][Full Text] [Related]
11. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
Gebauer K; Shumack S; Cowen PS
Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study.
Garbe C; Basset-Seguin N; Poulin Y; Larsson T; Østerdal ML; Venkata R; Lear JT
Br J Dermatol; 2016 Mar; 174(3):505-13. PubMed ID: 26471889
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
[TBL] [Abstract][Full Text] [Related]
14. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.
Kern JS; Sprecher E; Fernandez MF; Schauer F; Bodemer C; Cunningham T; Löwe S; Davis C; Sumeray M; Bruckner AL; Murrell DF;
Br J Dermatol; 2023 Jan; 188(1):12-21. PubMed ID: 36689495
[TBL] [Abstract][Full Text] [Related]
16. Ingenol mebutate gel for actinic keratosis.
Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
[TBL] [Abstract][Full Text] [Related]
17. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report.
Seckin D; Cerman AA; Yildiz A; Ergun T
J Drugs Dermatol; 2009 May; 8(5):451-4. PubMed ID: 19537367
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial.
Yang CC; Wong TW; Lee CH; Hong CH; Chang CH; Lai FJ; Lin SH; Chi CC; Lin TK; Yen H; Wu CH; Sheu HM; Lan CE
J Dermatol Sci; 2018 Jun; 90(3):295-302. PubMed ID: 29530340
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Actinic Keratoses Using Topical DNA Repair Enzymes: A Randomized Placebo-Controlled Trial.
Stoddard M; Herrmann J; Moy L; Moy R
J Drugs Dermatol; 2017 Oct; 16(10):1030-1034. PubMed ID: 29036257
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
